Gene · 3113
Papers2,625
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 2,625
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive Analysis of the PRDXs Family in Head and Neck Squamous Cell Carcinoma. | Front Oncol | 2022 | 35350568 | PubTator, text mining | PubMed |
| TP53/BRAF mutation as an aid in predicting response to immune-checkpoint inhibitor across multiple cancer types. | Aging (Albany NY) | 2022 | 35344507 | PubTator, text mining | PubMed |
| Ferroptosis-associated molecular classification characterized by distinct tumor microenvironment profiles in colorectal cancer. | Int J Biol Sci | 2022 | 35342352 | PubTator, text mining | PubMed |
| HLA class II immunogenic mutation burden predicts response to immune checkpoint blockade. | Ann Oncol | 2022 | 35339648 | PubTator, text mining | PubMed |
| Infection of Human Endothelial Cells with Lassa Virus Induces Early but Transient Activation and Low Type I IFN Response Compared to the Closely-Related Nonpathogenic Mopeia Virus. | Viruses | 2022 | 35337059 | PubTator, text mining | PubMed |
| HLA autoimmune risk alleles restrict the hypervariable region of T cell receptors. | Nat Genet | 2022 | 35332318 | PubTator, text mining | PubMed |
| Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome. | EBioMedicine | 2022 | 35325780 | PubTator, text mining | PubMed |
| Analysis of HLA Variants and Graves' Disease and Its Comorbidities Using a High Resolution Imputation System to Examine Electronic Medical Health Records. | Front Endocrinol (Lausanne) | 2022 | 35321340 | PubTator, text mining | PubMed |
| Chemokine CCL17 Affects Local Immune Infiltration Characteristics and Early Prognosis Value of Lung Adenocarcinoma. | Front Cell Dev Biol | 2022 | 35321241 | PubTator, text mining | PubMed |
| Promoting role of pentraxin-3 in esophageal squamous cell carcinoma. | Mol Ther Oncolytics | 2022 | 35317523 | PubTator, text mining | PubMed |
| Systematic analysis of the expression and prognostic value of ITPR1 and correlation with tumor infiltrating immune cells in breast cancer. | BMC Cancer | 2022 | 35313846 | PubTator, text mining | PubMed |
| The Prognostic Value and Immunological Role of STEAP1 in Pan-Cancer: A Result of Data-Based Analysis. | Oxid Med Cell Longev | 2022 | 35313641 | PubTator, text mining | PubMed |
| Diagnostic Value, Prognostic Value, and Immune Infiltration of LOX Family Members in Liver Cancer: Bioinformatic Analysis. | Front Oncol | 2022 | 35311155 | PubTator, text mining | PubMed |
| Combined Single Cell Transcriptome and Surface Epitope Profiling Identifies Potential Biomarkers of Psoriatic Arthritis and Facilitates Diagnosis via Machine Learning. | Front Immunol | 2022 | 35309349 | PubTator, text mining | PubMed |
| CTHRC1 is a prognosis-related biomarker correlated with immune infiltrates in colon adenocarcinoma. | World J Surg Oncol | 2022 | 35307012 | PubTator, text mining | PubMed |
| Bioinformatical analysis of the key differentially expressed genes and associations with immune cell infiltration in development of endometriosis. | BMC Genom Data | 2022 | 35303800 | PubTator, text mining | PubMed |
| BTG2 Serves as a Potential Prognostic Marker and Correlates with Immune Infiltration in Lung Adenocarcinoma. | Int J Gen Med | 2022 | 35300128 | PubTator, text mining | PubMed |
| FAT10 is a Prognostic Biomarker and Correlated With Immune Infiltrates in Skin Cutaneous Melanoma. | Front Mol Biosci | 2022 | 35300113 | PubTator, text mining | PubMed |
| A genome-scale screen for synthetic drivers of T cell proliferation. | Nature | 2022 | 35296855 | PubTator, text mining | PubMed |
| Possible Paternal Hepatitis B Virus Infection with Different Clinical Courses between Siblings: A Report of Two Cases. | Case Reports Hepatol | 2022 | 35295682 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3113/papers?page=47